Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: E9B192
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 14 |
GO:0003723 | RNA binding | 4 | 14 |
GO:0005488 | binding | 1 | 14 |
GO:0097159 | organic cyclic compound binding | 2 | 14 |
GO:1901363 | heterocyclic compound binding | 2 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 53 | 57 | PF00656 | 0.493 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.698 |
CLV_PCSK_PC1ET2_1 | 103 | 105 | PF00082 | 0.715 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.619 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.664 |
DOC_CYCLIN_RxL_1 | 103 | 115 | PF00134 | 0.725 |
DOC_MAPK_DCC_7 | 103 | 111 | PF00069 | 0.707 |
DOC_MAPK_gen_1 | 103 | 111 | PF00069 | 0.690 |
DOC_MAPK_MEF2A_6 | 70 | 77 | PF00069 | 0.590 |
DOC_PP1_RVXF_1 | 2 | 9 | PF00149 | 0.626 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.736 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.593 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.626 |
LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.508 |
LIG_APCC_ABBA_1 | 34 | 39 | PF00400 | 0.540 |
LIG_LIR_Gen_1 | 115 | 126 | PF02991 | 0.644 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.707 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.471 |
LIG_PTB_Apo_2 | 14 | 21 | PF02174 | 0.508 |
LIG_PTB_Phospho_1 | 135 | 141 | PF10480 | 0.425 |
LIG_PTB_Phospho_1 | 14 | 20 | PF10480 | 0.508 |
LIG_SH2_CRK | 118 | 122 | PF00017 | 0.645 |
LIG_SH2_CRK | 28 | 32 | PF00017 | 0.561 |
LIG_SH2_NCK_1 | 44 | 48 | PF00017 | 0.498 |
LIG_SH2_SRC | 44 | 47 | PF00017 | 0.523 |
LIG_SH2_STAT3 | 88 | 91 | PF00017 | 0.654 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.495 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.625 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.561 |
LIG_SUMO_SIM_par_1 | 107 | 113 | PF11976 | 0.728 |
LIG_SUMO_SIM_par_1 | 73 | 79 | PF11976 | 0.629 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.699 |
LIG_TYR_ITIM | 47 | 52 | PF00017 | 0.508 |
LIG_UBA3_1 | 74 | 80 | PF00899 | 0.645 |
LIG_WW_3 | 104 | 108 | PF00397 | 0.711 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.552 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.636 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.644 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.308 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.521 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.540 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.552 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.542 |
MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.340 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.517 |
MOD_NEK2_2 | 27 | 32 | PF00069 | 0.574 |
MOD_OFUCOSY | 64 | 69 | PF10250 | 0.662 |
MOD_Plk_1 | 10 | 16 | PF00069 | 0.540 |
MOD_Plk_1 | 45 | 51 | PF00069 | 0.523 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.620 |
MOD_SUMO_rev_2 | 95 | 105 | PF00179 | 0.683 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.718 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.469 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.498 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.491 |
TRG_Pf-PMV_PEXEL_1 | 107 | 112 | PF00026 | 0.715 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5Z2 | Leptomonas seymouri | 86% | 100% |
A0A0S4J311 | Bodo saltans | 33% | 100% |
A0A0S4JKJ5 | Bodo saltans | 48% | 76% |
A0A1X0P0Y7 | Trypanosomatidae | 29% | 100% |
A0A1X0P2H6 | Trypanosomatidae | 53% | 100% |
A0A3Q8II67 | Leishmania donovani | 97% | 100% |
A4HIQ2 | Leishmania braziliensis | 91% | 100% |
A4I5Z5 | Leishmania infantum | 97% | 100% |
C9ZRC4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 92% |
D0A516 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
Q4Q6X2 | Leishmania major | 96% | 100% |
V5BSJ4 | Trypanosoma cruzi | 55% | 93% |